Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05710536

Safety and Efficacy of Formulation for Improving Vagina Laxity

Conditions: Healthy, Vagina Laxity

Sex: Female
Ages: 40 Years – 55 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 18
Sponsor: Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Location: Malaysia

Summary

This study is conducted to investigate the safety and efficacy of the formulation containing stem cell secretome, cobrotoxin (CTX) peptides, Sophora Flavescens root extract and licorice root extract in improving vagina laxity (VL) condition of women in Malaysia. This formulation may stimulate cell rejuvenation and trigger cell renewal efficiently as they contained rich mixture of natural, bioavailable polypeptides and plant extracts and these might help improving the VL condition in women. The study duration is 5 weeks and vagina assessment will be carried out at baseline, week 2 and week 5.The main objectives of this study are:To assess the vagina laxity of women in Malaysia after using the formulation.To observe any adverse effect occurrence with the use of the formulation.

Eligibility Criteria

Inclusion Criteria:Malaysian women ( age 40 to 55 years old)Complaint of vagina laxityWillingness to participate in the studyExclusion Criteria:Pregnant and breastfeeding womenDoing any surgical or non-surgical procedures to improved vaginal laxity condition such as laser and radiofrequency before participating in the study that might affect the study outcomePresence of illness or taking any medication that might impact the study outcome or participants well-being

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05710536). StuddyBuddy aggregates publicly available trial information.